Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis-Reference-Cited by-同舟云学术

Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis

Published:2019-03-20 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lin Chiou-Hong,Wang Zhong,Duque-Afonso Jesús,Wong Stephen Hon-Kit,Demeter Janos,Loktev Alexander V.,Somervaille Tim C. P.,Jackson Peter K.,Cleary Michael L.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-41393-w.pdf

Reference53 articles.

1. Look, A. T. Oncogenic transcription factors in the human acute leukemias. Science 278, 1059–1064 (1997).

2. So, C. W. & Cleary, M. L. Dimerization: a versatile switch for oncogenesis. Blood 104, 919–922, https://doi.org/10.1182/blood-2004-03-0992 (2004).

3. Sun, X. J. et al. A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis. Nature 500, 93–97, https://doi.org/10.1038/nature12287 (2013).

4. Smith, M. J. et al. Evolution of AF6-RAS association and its implications in mixed-lineage leukemia. Nat Commun 8, 1099, https://doi.org/10.1038/s41467-017-01326-5 (2017).

5. Kolibaba, K. S. & Druker, B. J. Protein tyrosine kinases and cancer. Biochim Biophys Acta 1333, F217–248 (1997).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive summary: the role of PBX1 in development and cancers;Frontiers in Cell and Developmental Biology;2024-07-26

2. PBX1: a TALE of two seasons—key roles during development and in cancer;Frontiers in Cell and Developmental Biology;2024-02-09

3. The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia;Annals of Hematology;2023-12-27

4. Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies;Cancer Cell;2023-12

5. The TALE never ends: A comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects;Human Mutation;2022-05-18